ClinicalTrials.gg
Not yet recruitingNCT07898527Updated Oct 27, 2026

Effect of AI-Based Image Generation on Children's Ecological Footprint Awareness

An interventional study of AI-Based Image Generation Activity in Environmental Awareness, Ecological Footprint and Healthy Children, sponsored by Balikesir University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 60 Months to 72 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-27.

Sponsored by Balikesir University · Not applicable, Interventional, and Other

Updated Oct 27, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
60 Months to 72 Months
Sex
All
01

Study summary

The aim of this study is to examine the effect of artificial intelligence-based image generation on children's ecological footprint awareness. The study is designed as a two-group randomized controlled trial and will be conducted with children aged 60-72 months attending two public preschools in Turkiye. Children will be randomly assigned to an intervention group or a control group. Children in the intervention group will take part in a 20-minute AI-based image generation activity on ecological footprint topics, while children in the control group will receive no intervention. Ecological footprint awareness will be measured in both groups before the intervention (pretest) and 20 days after the intervention (posttest). The study seeks to determine whether AI-based image generation increases children's ecological footprint awareness.

02

Conditions studied

  • Environmental Awareness
  • Ecological Footprint
  • Healthy Children

Keywords

  • Artificial Intelligence
  • AI-Based Image Generation
  • Preschool Children
  • Environmental Education
  • Sustainability
  • Pediatric Nursing
03

In context

Lead sponsor

Balikesir University is the lead sponsor of 62 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Months to 72 Months
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria (intervention and control groups):

  • Child has adequate visual, auditory and cognitive abilities to participate in the study
  • Written obtained from the parent(s)
  • Complete data collection form
  • Child is 60-72 months of age

Exclusion Criteria:

  • Child does not have adequate visual, auditory or cognitive abilities to participate in the study
  • Informed consent not obtained from the parent(s)
  • Incomplete data collection form
  • Child is not 60-72 months of age
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Intervention Group

    Children aged 60-72 months who take part in a 20-minute AI-based image generation activity on ecological footprint topics. Pretest before the intervention and posttest 20 days after the intervention.

    Behavioral: AI-Based Image Generation Activity

  • No intervention
    Control Group

    Children aged 60-72 months who receive no intervention. Pretest and posttest are administered at the same time points as the intervention group.

Interventions

  • BehavioralAI-Based Image Generation Activity

    Children in the intervention group take part in a 20-minute activity in which they create images on ecological footprint topics using an artificial intelligence-based image generation tool. Ecological footprint awareness is measured with the Ecological Footprint Awareness Scale for Children (EKAY-O) before the intervention and 20 days after the intervention.

06

What researchers measure

Primary outcomes

  1. Change in Ecological Footprint Awareness Score

    Ecological footprint awareness will be assessed with the Ecological Footprint Awareness Scale for Children (EKAY-O). The change in total scale score from pretest to posttest will be compared between the intervention and control groups. Higher scores indicate higher ecological footprint awareness.

    Time frame: Baseline (pretest, before the intervention) and 20 days after the intervention (posttest)

07

Study locations

1 site
  • Public Preschools in Balikesir
    Balıkesir, Turkey (Türkiye)
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — Individual participant data will not be shared in order to protect the privacy and confidentiality of the child participants.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Nov 2026; primary completion for Jan 2027, 2 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 20, 2026
First posted
Oct 27, 2026
StartEst.
Nov 1, 2026
Primary completionEst.
Jan 1, 2027
CompletionEst.
May 1, 2027
Last update
Oct 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 27, 2026
Show all 1 update
  1. Oct 27, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07898527
Lead sponsor
Balikesir University
Collaborators
The Scientific and Technological Research Council of Turkey
Responsible party
Sibel Ergün (Professor, Balikesir University) — Principal investigator
First posted
Oct 27, 2026
Start date
Nov 1, 2026 (estimated)
Primary completion
Jan 1, 2027 (estimated)
Completion
May 1, 2027 (estimated)
Last update
Oct 27, 2026

Study contacts

Hilal Çelik Bayram
Contact
hems.hilalcelik@gmail.com
05419699593

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion